FGL2 and colon adenocarcinoma: In COAD, FGL2 can be used as a new prognostic marker and an effective therapeutic target, and the overexpression of FGL2 enhances cancer cell invasion, induces epithelial mesenchymal transition (EMT), and promotes COAD invasion and metastasis (50).